相关实验视频

Updated: Jan 6, 2026

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

与阿尔茨海默氏病相关的PLCG2变异改变了人类诱导的多能干细胞衍生的微状细胞中的微状体状态和功能

Logan M Bedford^1,2, Kaylee D Tutrow^1,3, Karly Hooper³

¹Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association

|October 9, 2025

概括

脂酶C玛2 (PLCG2) 的遗传变异通过改变微质功能,影响阿尔茨海默病的风险. 了解这些PLCG2变体是开发神经炎症新疗法的关键.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
遗传学遗传学是一个

背景情况:

脂酶C玛2 (PLCG2) 是一个关键的微质免疫信号蛋白.
PLCG2中的遗传变异与阿尔茨海默病 (AD) 风险有关.
调查PLCG2变体对微质细胞的影响对于了解AD病变的产生至关重要.

研究的目的:

确定保护性 (PLCG2^P522R) 和风险转移性 (PLCG2^M28L) PLCG2变体对微质转录组和功能的影响.
为了比较PLCG2变体与微质中的PLCG2缺陷的影响.

主要方法:

诱导多能干细胞 (iPSC) 衍生微质的产生,具有特定的PLCG2变体或淘汰赛 (KO).
微质转录组和功能反应的分析.
评估TREM2表达,炎症反应,增殖和亡.

主要成果:

在转录学上,PLCG2^P522R微质类似于控制体.
PLCG2^M28L微质与PLCG2^KO微质有相似之处,TREM2减少,炎症减弱,并改变了增殖/亡.
在LPS刺激时,PLCG2^P522R微质表现出增强的细胞因子分泌和亡抵抗.

结论:

PLCG2变异明显改变微质转录组和功能,影响AD风险和保护.
准PLCG2信号提供了一个潜在的治疗策略,用于AD的神经炎症.
由PLCG2变体介导的微质反应差异影响AD的发病性.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.这就是PLCG2的原因.RNA:序列分析,RNA:RNA的序列分析.灭症 (apoptosis) 是一种死亡的过程.细胞死亡是细胞死亡.细胞的增殖细胞的增殖.对疾病的遗传倾向.遗传变异是一种遗传变异.诱导多能干细胞的诱导干细胞.微质细胞中的微质细胞现象型现象型是一种现象型.

更多相关视频

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Published on: May 31, 2022

The Specification of Telencephalic Glutamatergic Neurons from Human Pluripotent Stem Cells

The Specification of Telencephalic Glutamatergic Neurons from Human Pluripotent Stem Cells

Published on: April 14, 2013

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...